Sentinel node biopsy and standard of care for melanoma

Journal of the American Academy of Dermatology

Volumn 60, Issue 5, 2009, Pages 872-875

  Balch, Charles M ^a,b   Morton, Donald L ^c   Gershenwald, Jeffrey E ^b,d   McMasters, Kelly M ^e   Nieweg, Omgo E ^f   Powell, Barry ^g   Ross, Merrick I ^d   Sondak, Vernon K ^h   Thompson, John F ^i,j  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b American Joint Committee on Cancer   (United States)

^c JOHN WAYNE CANCER INSTITUTE   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e University of Louisville School of Medicine   (United States)

^f NETHERLANDS CANCER INSTITUTE   (Netherlands)

^g ST GEORGE S HOSPITAL   (United Kingdom)

^h H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

ⁱ MELANOMA INSTITUTE AUSTRALIA   (Australia)

^j UNIVERSITY OF SYDNEY   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ASPIRATION BIOPSY; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; ECHOGRAPHY; EDITORIAL; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MEDICAL SOCIETY; MELANOMA; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

HUMANS; LYMPH NODE EXCISION; MELANOMA; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY; SOCIETIES, MEDICAL;

EID: 65249174648     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.09.067     Document Type: Editorial

References (9)

1. McMasters K.M., Reintgen D.S., Ross M.I., Gershenwald J.E., Edwards M.J., Sober A., et al. Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol 19 (2001) 2851-2855
2. McMasters K.M. What good is sentinel lymph node biopsy for melanoma if it does not improve survival?. Ann Surg Oncol 11 (2004) 810-812
3. Morton D.L., Cochran A.J., Thompson J.F., Elashoff R., Essner R., Glass E.C., et al. Multicenter Selective Lymphadenectomy Trial Group. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 242 (2005) 302-311
4. Morton D.L., Thompson J.F., Cochran A.J., Mozzillo N., Elashoff R., Essner R., et al. MSLT Group. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355 (2006) 1307-1317
5. Bleicher R.J., Essner R., Foshag L.J., Wanek L.A., and Morton D.L. Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas. J Clin Oncol 21 (2003) 1326-1331
6. Balch C.M., and Cascinelli N. Sentinel-node biopsy in melanoma. N Engl J Med 355 (2006) 1370-1371
7. Thomas J.M. Prognostic false-positivity of the sentinel node in melanoma. Nat Clin Pract Oncol 5 (2008) 18-23
8. Morton D.L., Cochran A.J., and Thompson J.F. The rationale for sentinel-node biopsy in primary melanoma. Nat Clin Pract Oncol 5 (2008) 510-511
9. Ross M.I., and Gershenwald J.E. How should we view the results of the multicenter selective lymphadenectomy trial-1 (MSLT-1)?. Ann Surg Oncol 15 (2008) 670-673